Bisgard, Kristine M. DVM, MPH*; Pascual, F Brian MPH*; Ehresmann, Kristen R. RN, MPH†; Miller, Claudia A. MS†; Cianfrini, Christy MPH*; Jennings, Charles E. BS‡; Rebmann, Catherine A. MPH§; Gabel, Julie DVM, MPH§; Schauer, Stephanie L. PhD∥; Lett, Susan M. MD, MPH∥
From the *Bacterial Vaccine Preventable Diseases Branch, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA; the †Minnesota Department of Health, Minneapolis, MN; the ‡Illinois Department of Public Health, Springfield, IL; the §Georgia Division of Public Health, Atlanta, GA; and the ∥Massachussetts Department of Public Health, Jamaica Plain, MA
Accepted for publication September 8, 2004.
Supported by the National Immunization Program, U.S. Centers for Disease Control and Prevention.
Ms. Cianfrini's current affiliation: élan Pharmaceuticals, Inc., 7475 Lusk Boulevard, San Diego, CA 92121.
Reprints not available.